![Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor? Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?](https://www.mdpi.com/genes/genes-10-00208/article_deploy/html/images/genes-10-00208-g001.png)
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png)
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
![Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrm2653/MediaObjects/41580_2009_Article_BFnrm2653_Fig1_HTML.jpg)
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
![Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrm3819/MediaObjects/41580_2014_Article_BFnrm3819_Fig1_HTML.jpg)
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
![Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/17/20/6459/F1.large.jpg)
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
![Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL](https://xpic.x-mol.com/20200617%2F10.1016_j.celrep.2020.107757.jpg)
Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL
![Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/22a093811fa1404a83b7a26e3330d029c694d545/3-Figure2-1.png)
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
![Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma](https://f6publishing.blob.core.windows.net/6c402b91-45fd-4c62-9a40-9b8131741e0c/WJG-26-4786-g004.png)
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma
![Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/492867/492867_Thumb_400.jpg)
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology
![Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML](https://www.mdpi.com/cancers/cancers-09-00131/article_deploy/html/images/cancers-09-00131-g001.png)
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
![Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c69c63e232fe5d05c665808f0c485d5f3ff15102/8-Figure3-1.png)
Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar
![Structure and function of the human Polo-like kinases: (A) Polo-like... | Download Scientific Diagram Structure and function of the human Polo-like kinases: (A) Polo-like... | Download Scientific Diagram](https://www.researchgate.net/publication/334148435/figure/fig1/AS:775911792197632@1562003195090/Structure-and-function-of-the-human-Polo-like-kinases-A-Polo-like-kinases-in-human.png)